What are the limitations of the hirsutism severity mfg score?

While the hirsutism severity mfg score is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the hirsutism severity mfg score to ensure safe bedside use and optimal diagnostic accuracy.

How does the hirsutism severity mfg score compare to other Endocrinology scores?

The hirsutism severity mfg score is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the hirsutism severity mfg score free to use?

Yes. OpiCalc provides the hirsutism severity mfg score completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

Hirsutism severity mfg score Score and Guidance

CLINICAL REFERENCE

CLINICAL INSIGHT

When to Use

Clinical assessment of terminal hair growth in women.
Diagnosis of hyperandrogenism (PCOS, Adrenal hyperplasia).
Monitoring response to anti-androgen or laser hair removal therapy.
Evaluating secondary sexual characteristics in endocrine workups.

CLINICAL INSIGHT

How it Works

Defining Terminal Hair

The scale only counts "terminal hair" (pigmented, stiff, usually >5mm) and ignores vellus hair (fine, soft, non-pigmented). Each of the 9 body areas is scored from 0 (no hair) to 4 (frankly virile).

Body Areas

Upper Lip, Chin, Chest
Upper Abdomen, Lower Abdomen
Upper Arms, Thighs
Upper Back, Lower Back

CLINICAL INSIGHT

Practical Pearls

Ethnic Variations

The definition of "abnormal" varies by ethnicity. General threshold is ≥ 8. In East Asian populations, a score ≥ 4 is often considered significant, whereas in Mediterranean or Hispanic populations, higher scores (up to 9 or 10) may be normal.

Management Note

Wait at least 6 months after starting medical therapy (e.g., Spironolactone or OCPs) to re-evaluate the mFG score, as the hair growth cycle is slow and current terminal hairs must be shed first.

CLINICAL INSIGHT

Evidence Base

Primary Source

Clinical assessment of body hair growth in women.

Ferriman D, Gallwey JD.J Clin Endocrinol Metab1961

Visually scoring hirsutism as a tool for clinical practice.

Yildiz BO, et al.Hum Reprod Update2010

When to Use

When to Use

How it Works

Defining Terminal Hair

Body Areas

Practical Pearls

Ethnic Variations

Management Note

Evidence Base

Primary Source

Hirsutism Severity (mFG Score)

0

When to Use

When to Use

How it Works

Defining Terminal Hair

Body Areas

Practical Pearls

Ethnic Variations

Management Note

Evidence Base

Primary Source

Hirsutism Severity (mFG Score)

0

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Defining Terminal Hair

Body Areas

Practical Pearls

Ethnic Variations

Management Note

Evidence Base

Primary Source

Hirsutism Severity (mFG Score)

0

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Defining Terminal Hair

Body Areas

Practical Pearls

Ethnic Variations

Management Note

Evidence Base

Primary Source

Hirsutism Severity (mFG Score)

0